BVF Inc’s NGM Biopharmaceuticals NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-955,000
Closed -$14.6M – 84
2022
Q1
$14.6M Hold
955,000
– – 0.58% 46
2021
Q4
$16.9M Hold
955,000
– – 0.61% 43
2021
Q3
$20.1M Hold
955,000
– – 0.78% 38
2021
Q2
$18.8M Buy
+955,000
New +$22.4M 0.71% 39

Other funds holding NGM

BVF Inc's NGM Position: Q2 2022 in Review

BVF Inc sold out of NGM Biopharmaceuticals (NGM) in Q2 2022, closing a stake of 955,000 shares — an estimated $14.6M sold.

BVF Inc first reported a position in NGM in Q2 2021 and held it in 4 quarters. The position peaked at $20.1M in Q3 2021. 123 funds tracked by Wall St. Rank hold NGM as of Q2 2022.

  • BVF Inc reported no remaining NGM Biopharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • BVF Inc sold 955,000 NGM Biopharmaceuticals shares in Q2 2022, an estimated $14.6M.
  • BVF Inc first reported a position in NGM Biopharmaceuticals in Q2 2021 and held it in 4 quarters.
  • BVF Inc's NGM Biopharmaceuticals position peaked at $20.1M in Q3 2021.
  • 123 funds tracked by Wall St. Rank held NGM Biopharmaceuticals as of Q2 2022.

Based on BVF Inc's 13F filing for Q2 2022, filed 15 Aug 2022.